In the News

1853 News Items found
Chromosomes from a human male
In the Lab
During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.
Ross L. Levine, MD
The May 6 session of “MSK Science Spotlight” features Ross Levine, MD, Laurence Joseph Dineen Chair in Leukemia Research and Chief, Molecular Cancer Medicine Service, Human Oncology and Pathogenesis Program, presenting his work on “Deciphering and Targeting Clonal Evolution.”
MSK Information Sessions
Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus.
Andrea Schietinger, PhD
The May 4 session of “MSK Science Spotlight” will feature series host, Andrea Schietinger, PhD, Assistant Member, Immunology Program, SKI, presenting her own research, “Decoding T Cell Dysfunction in Tumors.” Dr. Schietinger, a former winner of the prestigious National Institutes of Health Director’s New Innovator Award, has served as host for past sessions of the online seminar series for the scientific community.
Fluorescent image of mouse prostate gland
In the Lab
Androgen-deprivation therapy, a mainstay of prostate cancer treatment, may give prostate cells new growth abilities, scientists at Memorial Sloan Kettering have found.
Four dogs wearing blue bandanas are held on leashes in a hallway at Memorial Hospital. Three handlers are seen only from the waist down.
Feature
The Caring Canines program at Memorial Sloan Kettering has been going strong for more than 12 years.
Memorial Sloan Kettering medical oncologist Andrea Cercek
In the Clinic
A new treatment is approved for an especially aggressive kind of colorectal cancer.
Scott Keeney, PhD
The April 29 session of “MSK Science Spotlight” will feature a lecture from newly elected member of the National Academy of Sciences (NAS), Scott Keeney, PhD.
Charles Sawyers, MD
During the opening clinical plenary of the American Association for Cancer Research (AACR) virtual annual meeting I on Monday, April 27, Memorial Sloan Kettering’s Charles Sawyers, MD served as a discussant and featured thought leader on two phase III BRAF-mutant melanoma trials, providing commentary and a broader outlook on the highlighted clinical trials.
Most Vulnerable Among Us
During the plenary session at the American Association for Cancer Research’s (AACR) virtual annual meeting I on Tuesday, April 28, Memorial Sloan Kettering (MSK) expert Louis P. Voigt, MD, Intensivist, spoke about disparities with cancer and COVID-19 patients.